Mobia Medical

Last updated: May 8, 2026
Ticker
MOBI
Exchange
NYSE
IPO Date
Pending
Price Range
$14.00 - $16.00
Deal Size
$150 million
View MOBI Live Chart on TradingViewAffiliate link — we may earn a commission.

Company Snapshot

Mobia Medical is a commercial-stage medical device company focused on redefining stroke recovery for survivors with motor impairments. The company's flagship product, the Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System, is designed to enhance recovery outcomes for stroke patients. Mobia Medical aims to address a significant healthcare burden associated with ischemic strokes through innovative technology.

Founded
2007

Key Financials

Metric20252024
Revenue$32.0B$15.6B
YoY Growth+105.1%-
Adjusted Net Loss-$46.5M-$24.6M
Margin %-0.1%-0.2%
Gross Margin
81%

Balance Sheet

Cash & Equivalents
$33.6M

Implied Valuation at Midpoint

Market Cap
$496M
P/S Ratio
0.0x

Based on price range midpoint and most recent fiscal year data.

S-1 Highlights

Market & Competition

The company operates in the medical device industry, specifically targeting stroke recovery solutions. Mobia Medical competes with companies such as MicroTransponder and others in the neurostimulation market.

Use of Proceeds

Proceeds from the IPO are expected to be utilized for general corporate purposes, which may include funding research and development, working capital, and potential acquisitions.

Key Risk Factors

  • Mobia Medical relies on a limited number of third-party contract manufacturers, which poses a risk if these suppliers fail to deliver necessary components.
  • The company has identified a material weakness in its internal control over financial reporting, which could impact its financial stability.

Deal Structure

Primary Shares
10,000,000 shares
Shares Outstanding
33,085,391 shares
Post-IPO Float
30.2%
Lock-up
No Lock-up Agreement
Lead Underwriters
BofA Securities, J.P. Morgan, Goldman Sachs & Co. LLC, BTIG, Wolfe, Nomura

Reported Broker Availability

No broker information available yet

Check back later for updates

Reported by users or publicly disclosed. Information is for reference only.

Important: Information presented on this website is aggregated from publicly available sources and voluntary user submissions. It is provided for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. IPO access and availability may vary by broker and is not guaranteed; always verify details directly with your broker before making any investment decisions. We are not affiliated with, endorsed by, or acting on behalf of any broker-dealers, underwriters, or issuing companies. Some links to broker platforms may be affiliate links, and we may earn a commission if you open an account through those links. See full disclaimer for additional information.